SS Innovations International (SSII) Net Cash Flow (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 948.69% |
| Dec 31, 2025 | 63.75% |
| Sep 30, 2025 | -14.81% |
| Jun 30, 2025 | -128.98% |
| Mar 31, 2025 | 63,841.99% |
| Dec 31, 2024 | 119.84% |
| Sep 30, 2024 | 74.66% |
| Jun 30, 2024 | -198.36% |
| Mar 31, 2024 | 96.32% |
| Dec 31, 2023 | -139.47% |
| Sep 30, 2023 | 4,980.26% |
| Jun 30, 2023 | 265.39% |
| Mar 31, 2023 | -37.90% |
| Dec 31, 2022 | 172.71% |
| Sep 30, 2022 | 103.14% |
| Jun 30, 2022 | -1,803.18% |
| Mar 31, 2022 | -129.37% |
| Dec 31, 2021 | 295.94% |
| Sep 30, 2021 | -378.41% |
| Jun 30, 2021 | -113.71% |
| Mar 31, 2021 | -2.45% |
| Dec 31, 2020 | 3,482.46% |
| Sep 30, 2020 | -0.57% |
| Jun 30, 2020 | 74.37% |
| Mar 31, 2020 | -1,129.34% |
| Dec 31, 2019 | 83.65% |
| Sep 30, 2019 | -117.37% |
| Jun 30, 2019 | 103.63% |
| Mar 31, 2019 | 140.04% |
| Dec 31, 2018 | 42.19% |
| Sep 30, 2018 | 9.33% |
| Jun 30, 2018 | 10.82% |
| Mar 31, 2018 | -101.95% |
| Dec 31, 2017 | -117.45% |
| Sep 30, 2017 | 410.75% |
| Jun 30, 2017 | -1,835.15% |
| Mar 31, 2017 | 117.92% |
| Dec 31, 2016 | 50.26% |